Moore L E
CRNA. 1995 Aug;6(3):135-8.
The purpose of this article is to determine the optimal monitoring for onset of neuromuscular blockade as it relates to mivacurium, a new short-acting nondepolarizing neuromuscular blocker. Clinically, mivacurium has a higher percentage of undesirable consequences to tracheal intubation such as: diaphramatic movement, coughing, and purposeful movement. It is important to understand the time line from onset to recovery with mivacurium and the best muscle to determine onset blockade to minimize these unwanted effects.
本文的目的是确定与米库氯铵（一种新型短效非去极化神经肌肉阻滞剂）相关的神经肌肉阻滞起效的最佳监测方法。临床上，米库氯铵在气管插管时产生不良后果的比例较高，如膈肌运动、咳嗽和自主运动。了解米库氯铵从起效到恢复的时间线以及用于确定阻滞起效的最佳肌肉，对于将这些不良影响降至最低非常重要。
